Priavoid aims to become a leading pharmaceutical company focusing on neurological disorders with unmet medical needs.
Our global growth strategy has three elements, centered around developing innovative therapies for neurological disorders, with a particular focus on drugs for the treatment of Alzheimer’s disease, ALS and neuropathic pain.